These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2864273)

  • 1. [3H]SCH 23390 labeled D1 dopamine receptors are unchanged in schizophrenia and Parkinson's disease.
    Pimoule C; Schoemaker H; Reynolds GP; Langer SZ
    Eur J Pharmacol; 1985 Aug; 114(2):235-7. PubMed ID: 2864273
    [No Abstract]   [Full Text] [Related]  

  • 2. Binding of [3H]SCH 23390 to D-1 receptors in the putamen of control and parkinsonian subjects.
    Raisman R; Cash R; Ruberg M; Javoy-Agid F; Agid Y
    Eur J Pharmacol; 1985 Jul; 113(3):467-8. PubMed ID: 2864270
    [No Abstract]   [Full Text] [Related]  

  • 3. D1 and D2-type dopamine receptors in patients with Parkinson's disease and progressive supranuclear palsy.
    Pierot L; Desnos C; Blin J; Raisman R; Scherman D; Javoy-Agid F; Ruberg M; Agid Y
    J Neurol Sci; 1988 Sep; 86(2-3):291-306. PubMed ID: 2975699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A post-mortem study on striatal dopamine receptors in Parkinson's disease.
    Rinne JO; Laihinen A; Lönnberg P; Marjamäki P; Rinne UK
    Brain Res; 1991 Aug; 556(1):117-22. PubMed ID: 1834312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective and stereospecific interactions of R-SK & F 38393 with [3H]piflutixol but not [3H]spiperone binding to striatal D1 and D2 dopamine receptors: comparisons with SCH 23390.
    O'Boyle KM; Waddington JL
    Eur J Pharmacol; 1984 Mar; 98(3-4):433-6. PubMed ID: 6144559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine D-1 receptor and cyclic AMP-dependent phosphorylation in Parkinson's disease.
    Cash R; Raisman R; Ploska A; Agid Y
    J Neurochem; 1987 Oct; 49(4):1075-83. PubMed ID: 2887632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The inhibition of dopamine D1 and D2 receptors in human putamen by antipsychotic drugs].
    Kobayashi T; Shimizu H; Toru M
    Yakubutsu Seishin Kodo; 1990 Jun; 10(2):331-4. PubMed ID: 1979198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Link between D1 and D2 dopamine receptors is reduced in schizophrenia and Huntington diseased brain.
    Seeman P; Niznik HB; Guan HC; Booth G; Ulpian C
    Proc Natl Acad Sci U S A; 1989 Dec; 86(24):10156-60. PubMed ID: 2574862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine receptor subtype imbalance in schizophrenia.
    Hess EJ; Bracha HS; Kleinman JE; Creese I
    Life Sci; 1987 Apr; 40(15):1487-97. PubMed ID: 2951573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human brain D1 and D2 dopamine receptors in schizophrenia, Alzheimer's, Parkinson's, and Huntington's diseases.
    Seeman P; Bzowej NH; Guan HC; Bergeron C; Reynolds GP; Bird ED; Riederer P; Jellinger K; Tourtellotte WW
    Neuropsychopharmacology; 1987 Dec; 1(1):5-15. PubMed ID: 2908095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Organization of dopamine D1 and D2 receptors in human striatum: receptor autoradiographic studies in Huntington's disease and schizophrenia.
    Joyce JN; Lexow N; Bird E; Winokur A
    Synapse; 1988; 2(5):546-57. PubMed ID: 2973147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decrease in [3H]cocaine binding to the dopamine transporter in Parkinson's disease.
    Pimoule C; Schoemaker H; Javoy-Agid F; Scatton B; Agid Y; Langer SZ
    Eur J Pharmacol; 1983 Nov; 95(1-2):145-6. PubMed ID: 6667712
    [No Abstract]   [Full Text] [Related]  

  • 13. Differential localization of dopamine D1 and D2 receptors in rat retina.
    Tran VT; Dickman M
    Invest Ophthalmol Vis Sci; 1992 Apr; 33(5):1620-6. PubMed ID: 1532792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine receptors, neuroleptics, and schizophrenia.
    Snyder SH
    Am J Psychiatry; 1981 Apr; 138(4):460-4. PubMed ID: 6111227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Striatal D1- and D2-dopamine receptor sites are separately detectable in vivo.
    Leslie CA; Bennett JP
    Brain Res; 1987 Jul; 415(1):90-7. PubMed ID: 2957025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of flunarizine with dopamine D2 and D1 receptors.
    Ambrosio C; Stefanini E
    Eur J Pharmacol; 1991 May; 197(2-3):221-3. PubMed ID: 1833208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevation of brain neuroleptic/dopamine receptors in schizophrenia.
    Lee T; Seeman P
    Am J Psychiatry; 1980 Feb; 137(2):191-7. PubMed ID: 6101525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of [3H]SCH 23390 to dopamine D-1 receptors in rat retina in vitro.
    Gredal O; Parkinson D; Nielsen M
    Eur J Pharmacol; 1987 Jun; 137(2-3):241-5. PubMed ID: 2886353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a D1 dopamine receptor, not linked to adenylate cyclase, on lactotroph cells.
    Schoors DF; Vauquelin GP; De Vos H; Smets G; Velkeniers B; Vanhaelst L; Dupont AG
    Br J Pharmacol; 1991 Aug; 103(4):1928-34. PubMed ID: 1833020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of SCH 23390, a D-1-selective antagonist, with the anterior pituitary D-2 receptors and prolactin secretion in the rat.
    Apud JA; Masotto C; Ongini E; Racagni G
    Eur J Pharmacol; 1985 Jun; 112(2):187-93. PubMed ID: 2863153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.